期刊
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
卷 47, 期 2, 页码 751-760出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/ijmm.2020.4812
关键词
Tat-aldose reductase; Parkinson' s disease; dopaminergic cells; oxidative stress; MAPKs; protein therapy
资金
- National Research Foundation of Korea (NRF) - Korea government (MIST) [NRF-2018R1A2B6001941]
- Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2019R1A6A1A11036849]
The Tat-AR protein showed protective effects against MPP+-induced cell death in SH-SY5Y cells and inhibited dopaminergic neuronal cell death in a mouse model of PD. These findings suggest that Tat-AR may be a useful therapeutic protein for Parkinson's disease.
Aldose reductase (AR) is known to detoxify aldehydes and prevent oxidative stress. Although AR exerts antioxidant effects, the role of AR in Parkinson's disease (PD) remains unclear. The objective of the present study was to investigate the protective effects of AR protein against 1-methyl-4-phenylpyridinium (MPP+)-induced SH-SY5Y cell death and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD in a mouse model using the cell permeable Tat-AR fusion protein. The results revealed that when Tat-AR protein was transduced into SH-SY5Y cells, it markedly protected the cells against MPP+-induced death and DNA fragmentation. It also reduced the activation of mitogen-activated protein kinase (MAPKs) and regulated the expression levels of Bcl-2, Bax and caspase-3. Immunohistochemical analysis revealed that when Tat-AR protein was transduced into the substantia nigra (SN) of mice with PD, it markedly inhibited dopaminergic neuronal cell death. Therefore, Tat-AR may be useful as a therapeutic protein for PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据